A Phenotypic Screen Identifies a Compound Series That Induces Differentiation of Acute Myeloid Leukemia Cells In Vitro and Shows Antitumor Effects In Vivo

Induction of differentiation is a promising therapeutic strategy against acute myeloid leukemia. However, current differentiation therapies are effective only to specific patient populations. To identify novel differentiation agents with wider efficacy, we developed a phenotypic high-throughput scre...

Descripción completa

Detalles Bibliográficos
Autores: Josa-Culleré, Laia, Madden, Katrina S., Cogswell, Thomas J., Jackson, Thomas R., Carter, Tom S., Zhang, Douzi, Trevitt, Graham, Davies, Stephen G., Vyas, Paresh, Wynne, Graham M., Milne, Thomas A., Russell, Angela J.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/413054
Acceso en línea:http://hdl.handle.net/10261/413054
https://api.elsevier.com/content/abstract/scopus_id/85118580909
Access Level:acceso abierto
Palabra clave:Cancer
Antitumor Effects
http://metadata.un.org/sdg/9
http://metadata.un.org/sdg/3
Ensure healthy lives and promote well-being for all at all ages
Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation
Descripción
Sumario:Induction of differentiation is a promising therapeutic strategy against acute myeloid leukemia. However, current differentiation therapies are effective only to specific patient populations. To identify novel differentiation agents with wider efficacy, we developed a phenotypic high-throughput screen with a range of genetically diverse cell lines. From the resulting hits, one chemical scaffold was optimized in terms of activity and physicochemical properties to yield OXS007417, a proof-of-concept tool compound, which was also able to decrease tumor volume in a murine in vivo xenograft model.